Q3 2025 Earnings Call October 23, 2025 8:00 AM EDTCompany ParticipantsAlexandra Deignan - Head of Treasury & IRPeter Orszag ...
"Leverages proven technologies." Startup to tap into seriously powerful underground energy source: 'Emerging market' first ...
Retinol is the gold standard for reducing fine lines, blemishes, and dark spots. Byoma makes an affordable retinol oil that’s ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
Due to industrial groundwater pumping, the unincorporated town of Wenden in La Paz County is sinking. A local leader calls ...
Amplify is a long-running experiment to build a type of exoskeleton that helps people run and walk with reduced effort.
Solana’s Pump.fun buys Padre trading terminal to enhance liquidity and trading activity amid a sharp cooldown in the memecoin ...
Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...
The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...
The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...
Which will apparently lead to "a new future for running, jogging, and walking", says the sportswear giant. So, it sounds like ...
Cardiac performance in patients with HF can be determined with measurement of the time for peak oxygen uptake to decrease by more than 12.5%.